Skip to main content
. 2020 Feb 4;122(7):986–994. doi: 10.1038/s41416-020-0744-7

Fig. 3. Nintedanib inhibits the ICC-promoting effects of CAFs.

Fig. 3

a The proliferation-enhancing effects of CAF–CM on HuCCT1 and RBE are eliminated by nintedanib treatment (n = 5). *P < 0.01. b The invasiveness-enhancing effects of CAF–CM on HuCCT1 and RBE are decreased by nintedanib treatment (n = 5). *P < 0.01.